TRIAL DETAIL
Rechallenge of Imatinib in GIST Having no Effective Treatment (RIGHT)
Drug: |
||||
|---|---|---|---|---|
Trial Name: |
Rechallenge of Imatinib in GIST Having no Effective Treatment (RIGHT) |
|||
NCT#: |
||||
Conditions: |
Gastrointestinal Stromal Tumor |
|||
Status: |
Completed |
|||
Phase: |
3 |
Start Date 06/01/2010 |
Age of Trial (yrs) 14.8 |
|
Treatment Phase: |
Gleevec-resistant |
|||
Drug Category: |
KIT/PDGFRA inhibitor |
|||
Strategy: |
Block KIT |
|||
Trial Type: |
Specifically GIST and only GIST |
|||
Other Protocol IDs: |
AMC-ONCGI-1001 |
|||
Sponsor: |
Asan Medical Center |
|||
Patient Contact: |
Yoon-Koo Kang, MD, PhD
+82-2-3010-3230
ykkang@amc.seoul.kr
Min-Hee Ryu, MD, PhD
+82-2-3010-5935
miniryu@amc.seoul.kr
|
|||
Contact email: |
||||
Contact Phone: |
||||
Randomized: |
Randomized |
|||
IV or Oral: |
Oral |
|||
Trial Notes: |
This trial involves randomization and a placebo. The objective of this study is to compare the clinical outcomes following resumption of dosing (re-challenge) with Imatinib plus best supportive care versus placebo plus best supportive care in patients with advanced/incurable Gastrointestinal Stromal Tumors following failure of prior imatinib and sunitinib therapies. |
|||
Trial Links |
Trial Results |
Trial Sites
Name |
Address |
City |
State |
Zip |
Country |
Seoul |
Songpa-gu |
138-736 |
Republic of Korea |